Atlas Trials

Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors

Clinical trial NCT00027027 · COMPLETED

Trial details

NCT number
NCT00027027
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2001-11-01
Primary completion
2003-08-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.